{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:36:40Z","timestamp":1794454600330,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Psoriasis is a common, chronic immune-mediated systemic disease that had no effective and durable treatment. Mesenchymal stem cells (MSCs) have immunomodulatory properties. Therefore, we performed a phase 1\/2a, single-arm clinical trial to evaluate the safety and efficacy of human umbilical cord-derived MSCs (UMSCs) in the treatment of psoriasis and to preliminarily explore the possible mechanisms. Seventeen patients with psoriasis were enrolled and received UMSC infusions. Adverse events, laboratory parameters, PASI, and PGA were analyzed. We did not observe obvious side effects during the treatment and 6-month follow-up. A total of 47.1% (8\/17) of the psoriasis patients had at least 40% improvement in the PASI score, and 17.6% (3\/17) had no sign of disease or minimal disease based on the PGA score. And the efficiency was 25% (2\/8) for males and 66.7% (6\/9) for females. After UMSC transplantation (UMSCT), the frequencies of Tregs and CD4<jats:sup>+<\/jats:sup> memory T cells were significantly increased, and the frequencies of T helper (Th) 17 and CD4<jats:sup>+<\/jats:sup> naive T cells were significantly decreased in peripheral blood (PB) of psoriasis patients. And all responders showed significant increases in Tregs and CD4<jats:sup>+<\/jats:sup> memory T cells, and significant decreases in Th17 cells and serum IL-17 level after UMSCT. And baseline level of Tregs in responders were significantly lower than those in nonresponders. In conclusion, allogeneic UMSCT is safe and partially effective in psoriasis patients, and level of Tregs may be used as a potent biomarker to predict the clinical efficacy of UMSCT. Trial registration Clinical Trials NCT03765957<\/jats:p>","DOI":"10.1038\/s41392-022-01059-y","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:02:29Z","timestamp":1659657749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1\/2a, single-arm study"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8685-3674","authenticated-orcid":false,"given":"Lamei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7104-5490","authenticated-orcid":false,"given":"Cong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxue","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3645-7059","authenticated-orcid":false,"given":"Wu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1133-1791","authenticated-orcid":false,"given":"Yehong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-636X","authenticated-orcid":false,"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"1059_CR1","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi, R. et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 369, m1590 (2020).","journal-title":"BMJ"},{"key":"1059_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1684\/ejd.2012.1802","volume":"22","author":"X Ding","year":"2012","unstructured":"Ding, X. et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur. J. Dermatol. 22, 663\u2013667 (2012).","journal-title":"Eur. J. Dermatol."},{"key":"1059_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00441-022-03616-x","volume":"388","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Human umbilical cord-derived mesenchymal stem cells ameliorate psoriasis-like dermatitis by suppressing IL-17-producing gammadelta T cells. Cell Tissue Res. 388, 549\u2013563 (2022).","journal-title":"Cell Tissue Res."},{"key":"1059_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. N. W. N. Psoriasis. Lancet 397, 1301\u20131315 (2021).","journal-title":"Lancet"},{"key":"1059_CR5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","volume":"366","author":"KA Papp","year":"2012","unstructured":"Papp, K. A. et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N. Engl. J. Med. 366, 1181\u20131189 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1059_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song, N., Scholtemeijer, M. & Shah, K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol. Sci. 41, 653\u2013664 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"1059_CR7","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1089\/ten.tea.2008.0630","volume":"15","author":"O DelaRosa","year":"2009","unstructured":"DelaRosa, O. et al. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng. Part A 15, 2795\u20132806 (2009).","journal-title":"Tissue Eng. Part A"},{"key":"1059_CR8","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1073\/pnas.0910720107","volume":"107","author":"K Nemeth","year":"2010","unstructured":"Nemeth, K. et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc. Natl Acad. Sci. USA 107, 5652\u20135657 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1059_CR9","doi-asserted-by":"publisher","first-page":"11002","DOI":"10.1073\/pnas.0704421104","volume":"104","author":"LA Ortiz","year":"2007","unstructured":"Ortiz, L. A. et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl Acad. Sci. USA 104, 11002\u201311007 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1059_CR10","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.5966\/sctm.2015-0243","volume":"5","author":"A Rozenberg","year":"2016","unstructured":"Rozenberg, A. et al. Human mesenchymal stem cells impact Th17 and Th1 responses through a prostaglandin E2 and myeloid-dependent mechanism. Stem Cells Transl. Med. 5, 1506\u20131514 (2016).","journal-title":"Stem Cells Transl. Med."},{"key":"1059_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/cmi.2015.89","volume":"14","author":"D Wang","year":"2017","unstructured":"Wang, D. et al. The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol. Immunol. 14, 423\u2013431 (2017).","journal-title":"Cell Mol. Immunol."},{"key":"1059_CR12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/art.24405","volume":"60","author":"MA Gonzalez","year":"2009","unstructured":"Gonzalez, M. A., Gonzalez-Rey, E., Rico, L., Buscher, D. & Delgado, M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum. 60, 1006\u20131019 (2009).","journal-title":"Arthritis Rheum."},{"key":"1059_CR13","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","volume":"120","author":"J Xu","year":"2012","unstructured":"Xu, J. et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome. Blood 120, 3142\u20133151 (2012).","journal-title":"Blood"},{"key":"1059_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri3622","volume":"14","author":"PD Robbins","year":"2014","unstructured":"Robbins, P. D. & Morelli, A. E. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14, 195\u2013208 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"1059_CR15","first-page":"6961052","volume":"2019","author":"M Chen","year":"2019","unstructured":"Chen, M. et al. Mesenchymal stem cells alleviate moderate-to-severe psoriasis by reducing the production of type i interferon (IFN-I) by plasmacytoid dendritic cells (pDCs). Stem Cells Int. 2019, 6961052 (2019).","journal-title":"Stem Cells Int."},{"key":"1059_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2337\/dc15-0171","volume":"39","author":"J Cai","year":"2016","unstructured":"Cai, J. et al. Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: a pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion. Diabetes Care 39, 149\u2013157 (2016).","journal-title":"Diabetes Care"},{"key":"1059_CR17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/sctm.18-0031","volume":"7","author":"EH Park","year":"2018","unstructured":"Park, E. H. et al. Intravenous infusion of umbilical cord blood-derived mesenchymal stem cells in rheumatoid arthritis: a phase ia clinical trial. Stem Cells Transl. Med. 7, 636\u2013642 (2018).","journal-title":"Stem Cells Transl. Med."},{"key":"1059_CR18","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/ar4520","volume":"16","author":"D Wang","year":"2014","unstructured":"Wang, D. et al. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Res Ther. 16, R79 (2014).","journal-title":"Arthritis Res Ther."},{"key":"1059_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/ced.14269","volume":"45","author":"A Paganelli","year":"2020","unstructured":"Paganelli, A., Tarentini, E., Benassi, L., Kaleci, S. & Magnoni, C. Mesenchymal stem cells for the treatment of psoriasis: a comprehensive review. Clin. Exp. Dermatol. 45, 824\u2013830 (2020).","journal-title":"Clin. Exp. Dermatol."},{"key":"1059_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/bjd.20517","volume":"185","author":"SM Lwin","year":"2021","unstructured":"Lwin, S. M., Snowden, J. A. & Griffiths, C. E. M. The promise and challenges of cell therapy for psoriasis. Br. J. Dermatol. 185, 887\u2013898 (2021).","journal-title":"Br. J. Dermatol."},{"key":"1059_CR21","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3727\/096368916X691998","volume":"25","author":"MM De Jesus","year":"2016","unstructured":"De Jesus, M. M. et al. Autologous adipose-derived mesenchymal stromal cells for the treatment of psoriasis vulgaris and psoriatic arthritis: a case report. Cell Transplant. 25, 2063\u20132069 (2016).","journal-title":"Cell Transplant."},{"key":"1059_CR22","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.amjmed.2015.11.001","volume":"129","author":"H Chen","year":"2016","unstructured":"Chen, H. et al. Treatment of psoriasis with mesenchymal stem cells. Am. J. Med. 129, e13\u2013e14 (2016).","journal-title":"Am. J. Med."},{"key":"1059_CR23","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1681\/ASN.2017020151","volume":"28","author":"A Saad","year":"2017","unstructured":"Saad, A. et al. Autologous mesenchymal stem cells increase cortical perfusion in renovascular disease. J. Am. Soc. Nephrol. 28, 2777\u20132785 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1059_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/sctm.17-0219","volume":"7","author":"SY Ahn","year":"2018","unstructured":"Ahn, S. Y., Chang, Y. S., Sung, S. I. & Park, W. S. Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase I dose-escalation clinical trial. Stem Cells Transl. Med. 7, 847\u2013856 (2018).","journal-title":"Stem Cells Transl. Med."},{"key":"1059_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bjd.19380","volume":"184","author":"L Nussbaum","year":"2021","unstructured":"Nussbaum, L., Chen, Y. L. & Ogg, G. S. Role of regulatory T cells in psoriasis pathogenesis and treatment. Br. J. Dermatol. 184, 14\u201324 (2021).","journal-title":"Br. J. Dermatol."},{"key":"1059_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775\u2013787 (2008).","journal-title":"Cell"},{"key":"1059_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000238305","volume":"219","author":"P Quaglino","year":"2009","unstructured":"Quaglino, P. et al. Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology 219, 250\u2013258 (2009).","journal-title":"Dermatology"},{"key":"1059_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/ced.13795","volume":"44","author":"M Priyadarssini","year":"2019","unstructured":"Priyadarssini, M., Chandrashekar, L. & Rajappa, M. Effect of methotrexate monotherapy on T-cell subsets in the peripheral circulation in psoriasis. Clin. Exp. Dermatol. 44, 491\u2013497 (2019).","journal-title":"Clin. Exp. Dermatol."},{"key":"1059_CR29","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.4049\/jimmunol.167.4.1945","volume":"167","author":"S Gregori","year":"2001","unstructured":"Gregori, S. et al. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167, 1945\u20131953 (2001).","journal-title":"J. Immunol."},{"key":"1059_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/sji.12404","volume":"83","author":"L Zhang","year":"2016","unstructured":"Zhang, L. et al. Characterization of Th17 and FoxP3(+) Treg cells in paediatric psoriasis patients. Scand. J. Immunol. 83, 174\u2013180 (2016).","journal-title":"Scand. J. Immunol."},{"key":"1059_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","volume":"135","author":"L Zhang","year":"2010","unstructured":"Zhang, L., Yang, X. Q., Cheng, J., Hui, R. S. & Gao, T. W. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin. Immunol. 135, 108\u2013117 (2010).","journal-title":"Clin. Immunol."},{"key":"1059_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1541-4","volume":"16","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Serum IFN-gamma levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. J. Transl. Med. 16, 165 (2018).","journal-title":"J. Transl. Med."},{"key":"1059_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/scrt75","volume":"2","author":"MM Duffy","year":"2011","unstructured":"Duffy, M. M., Ritter, T., Ceredig, R. & Griffin, M. D. Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther. 2, 34 (2011).","journal-title":"Stem Cell Res Ther."},{"key":"1059_CR34","doi-asserted-by":"publisher","first-page":"118218","DOI":"10.1016\/j.lfs.2020.118218","volume":"259","author":"Z Bolandi","year":"2020","unstructured":"Bolandi, Z. et al. Adipose derived mesenchymal stem cell exosomes loaded with miR-10a promote the differentiation of Th17 and Treg from naive CD4(+) T cell. Life Sci. 259, 118218 (2020).","journal-title":"Life Sci."},{"key":"1059_CR35","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.1073\/pnas.1917834117","volume":"117","author":"F Facciotti","year":"2020","unstructured":"Facciotti, F. et al. Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6(+)B helper T cells in systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 117, 7305\u20137316 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1059_CR36","first-page":"310ra166","volume":"7","author":"R Li","year":"2015","unstructured":"Li, R. et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci. Transl. Med. 7, 310ra166 (2015).","journal-title":"Sci. Transl. Med."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01059-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:07:33Z","timestamp":1669230453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01059-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1038\/s41392-022-01059-y","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"assertion":[{"value":"29 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}